TickerFactsScreenerDevelopers

VYNE Therapeutics Inc. (VYNE) — EPS (Diluted)

Annual figures by fiscal year, from SEC filings.

2020: $7.882021: $-25.642022: $-7.282023: $-2.782024: $-0.932025: $-0.62$-0.62
2020EPS (Diluted) (USD/shares)2025
Fiscal YearEPS (Diluted)Change YoY
2025$-0.62+33.3%
2024$-0.93+66.5%
2023$-2.78+61.8%
2022$-7.28+71.6%
2021$-25.64-425.4%
2020$7.88—